Expertise in
8
conditions

Jozef Mardiak

Bratislava, BL, SK 
Expertise in
8
conditions
Bratislava, BL, SK 
OverviewLocationsClinical Research

Overview

Jozef Mardiak practices in Bratislava, Slovakia. Mr. Mardiak is highly rated in 8 conditions, according to our data. His top areas of expertise are Testicular Cancer, Choriocarcinoma, Breast Cancer, Peripheral Neuropathy, and Orchiectomy.

His clinical research consists of co-authoring 86 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Bratislava, BL, Slovakia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Study of Disulfiram and Cisplatin in Refractory TGCTs.
Phase II Study of Disulfiram and Cisplatin in Refractory TGCTs.
Enrollment Status: Completed
Publish Date: October 04, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase II Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Phase II Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Enrollment Status: Completed
Publish Date: March 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Treatment Strategy of the Use of 1st Line Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors Based on Tumor Marker Decline: A Phase II Trial of Paclitaxel, Ifosfamid and Cisplatin Regimen.
A Treatment Strategy of the Use of 1st Line Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors Based on Tumor Marker Decline: A Phase II Trial of Paclitaxel, Ifosfamid and Cisplatin Regimen.
Enrollment Status: Completed
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 2
Phase II Study of Avelumab in Multiple Relapsed/Refractory Testicular Germ Cell Cancer.
Phase II Study of Avelumab in Multiple Relapsed/Refractory Testicular Germ Cell Cancer.
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

86 Total Publications

Longitudinal Assessment of Cognitive Function in Survivors of Testicular Germ Cell Tumor.
Longitudinal Assessment of Cognitive Function in Survivors of Testicular Germ Cell Tumor.
Journal: European urology oncology
Published: May 24, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mardiak's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile